image
NextCure, Inc. NXTC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.31
-2.24 %
$ 36.7 M
Market Cap
-0.62
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 0.00% 9.66% 10.90%
Annual Report FY 10-K 2022-12-31 0.00% -0.06% -7.27%
Annual Report FY 10-K 2021-12-31 0.00% -109.07% -71.66%
Annual Report FY 10-K 2020-12-31 252.58% 1.62% -9.99%
Annual Report FY 10-K 2019-12-31 0.00% -47.98% -61.59%
Annual Report FY 10-K 2018-12-31 0.00% -47.39% -49.18%
Annual Report FY 10-K 2017-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% 19.31% 20.00%
Quarterly Report Q2 8-K 2024-06-30 0.00% 13.75% 13.91%
Quarterly Report Q1 8-K 2024-03-31 0.00% -13.13% 7.67%
Quarterly Report Q4 8-K 2023-12-31 0.00% 14.04% 11.15%
Quarterly Report Q3 8-K 2023-09-30 0.00% 23.04% 18.82%
Quarterly Report Q2 8-K 2023-06-30 0.00% -0.82% -5.68%
Quarterly Report Q1 8-K 2023-03-31 0.00% 26.00% 17.81%
Quarterly Report Q4 8-K 2022-12-31 0.00% 0.65% -4.10%
Quarterly Report Q3 8-K 2022-09-30 0.00% -3.64% -3.95%
Quarterly Report Q2 8-K 2022-06-30 0.00% 1.52% -0.98%
Quarterly Report Q1 8-K 2022-03-31 0.00% -23.59% -20.52%
Quarterly Report Q4 8-K 2021-12-31 0.00% -9.56% -5.14%
Quarterly Report Q3 8-K 2021-09-30 0.00% -9.55% -6.37%
Quarterly Report Q2 8-K 2021-06-30 0.00% -23.98% -13.61%
Quarterly Report Q1 8-K 2021-03-31 0.00% -169.87% -109.86%
Quarterly Report Q4 8-K 2020-12-31 -100.00% -41.49% -35.20%
Quarterly Report Q3 8-K 2020-09-30 0.00% -94.06% -79.33%
Quarterly Report Q2 8-K 2020-06-30 0.00% -76.47% -76.45%
Quarterly Report Q1 8-K 2020-03-31 1549.08% 258.13% -20.50%
Quarterly Report Q4 8-K 2019-12-31 0.00% -59.24% -69.94%
Quarterly Report Q3 8-K 2019-09-30 0.00% -47.71% -66.70%
Quarterly Report Q2 8-K 2019-06-30 0.00% -57.16% -68.96%
Quarterly Report Q1 8-K 2019-03-31 0.00% -23.20% -36.06%
Quarterly Report Q4 8-K 2018-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2018-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2018-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2018-03-31 0.00% 0.00% 0.00%